BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+44.04%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.32B
AUM Growth
+$1.32B
Cap. Flow
+$122M
Cap. Flow %
9.27%
Top 10 Hldgs %
60.28%
Holding
65
New
6
Increased
15
Reduced
13
Closed
8

Top Buys

1
PRNB
Principia Biopharma Inc. Common Stock
PRNB
$94M
2
IONS icon
Ionis Pharmaceuticals
IONS
$75.2M
3
CYTK icon
Cytokinetics
CYTK
$32.3M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
$24.5M
5
XOMA icon
Xoma
XOMA
$23.1M

Top Sells

1
GLPG icon
Galapagos
GLPG
$46.6M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$24.1M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$24.1M
4
MRUS icon
Merus
MRUS
$20.7M
5
BPMC
Blueprint Medicines
BPMC
$20.3M

Sector Composition

1 Healthcare 95.41%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XFOR icon
26
X4 Pharmaceuticals
XFOR
$70M
$12.2M 0.93%
1,141,974
+548,500
+92% +$5.87M
CTIC
27
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$10.9M 0.83%
6,929,690
– –
IDYA icon
28
IDEAYA Biosciences
IDYA
$2.26B
$10.8M 0.82%
1,436,429
-5,000
-0.3% -$37.5K
GLMD icon
29
Galmed Pharmaceuticals
GLMD
$7.07M
$10.6M 0.8%
1,832,484
– –
PRVL
30
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$10.4M 0.79%
656,483
– –
CDTX icon
31
Cidara Therapeutics
CDTX
$1.61B
$10.3M 0.78%
2,687,738
– –
AKRO icon
32
Akero Therapeutics
AKRO
$3.65B
$10M 0.76%
451,009
-20,737
-4% -$460K
CRVS icon
33
Corvus Pharmaceuticals
CRVS
$419M
$8.85M 0.67%
1,627,568
-1,419,587
-47% -$7.72M
VSTM icon
34
Verastem
VSTM
$585M
$8.48M 0.64%
6,328,994
– –
SPRO icon
35
Spero Therapeutics
SPRO
$117M
$8.13M 0.62%
845,405
-94,299
-10% -$907K
RNAC icon
36
Cartesian Therapeutics
RNAC
$267M
$7.82M 0.59%
+3,284,072
New +$7.82M
MRSN icon
37
Mersana Therapeutics
MRSN
$34.8M
$6.77M 0.51%
1,180,553
-2,861,335
-71% -$16.4M
CTMX icon
38
CytomX Therapeutics
CTMX
$350M
$6.37M 0.48%
766,148
-1,111,000
-59% -$9.23M
FWP
39
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$6.01M 0.46%
925,724
-5,554,355
-86% -$13
PTGX icon
40
Protagonist Therapeutics
PTGX
$3.62B
$4.81M 0.36%
682,630
– –
PHXM
41
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.55M 0.35%
625,000
– –
ALPN
42
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$4.37M 0.33%
1,137,764
– –
GNCA
43
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.35M 0.33%
2,100,305
– –
GMDA
44
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$4.3M 0.33%
1,000,000
– –
ARGX icon
45
argenx
ARGX
$44.2B
$4.01M 0.3%
+25,000
New +$4.01M
BLRX
46
BioLineRX
BLRX
$15.5M
$3.9M 0.3%
1,733,036
– –
STRO icon
47
Sutro Biopharma
STRO
$85.6M
$3.8M 0.29%
345,196
+1,000
+0.3% +$11K
OVID icon
48
Ovid Therapeutics
OVID
$94.6M
$3.05M 0.23%
734,301
-1,586,935
-68% -$6.59M
EIGR
49
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.14M 0.16%
143,567
-395,945
-73% -$5.9M
VIRX
50
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.09M 0.16%
6,194,925
– –
1
2
3